Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Oral 40% Destrogel to Prevent Hypoglycaemia in Late-term Births and SGA or LGA Term Newborns

NCT04185766 is registered in ClinicalTrials.gov with Fondazione Poliambulanza Istituto Ospedaliero as lead sponsor.

NCT NCT04185766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04185766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Oral 40% Destrogel to Prevent Hypoglycaemia in Late-term Births and SGA or LGA Term Newborns
Lead sponsor
Fondazione Poliambulanza Istituto Ospedaliero
Phase
Not applicable
Overall status
Completed
Start date
November 23, 2018
Completion date
May 5, 2019
Enrollment
172 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoglycaemia neonatal